Latest Breaking News On - Relationsjody cain - Page 1 : comparemela.com

Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead

Cocrystal Pharma Selects Novel Oral Protease Inhibitor CDI-988 as Norovirus Lead
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSam leeRelationsjody cainPartnersjules abrahamJames martinCenters for diseaseCocrystal pharma incHuman research ethics committeeNational institutes of healthClinical research organizationAustralia human research ethics committeesDisease controlCocrystal presidentNorovirus humanNational institutesCocrystal pharma

Cocrystal Pharma, Inc (COCP) Presents New Data from its CC-42344 Phase 1 Influenza A Study

Cocrystal Pharma, Inc (COCP) Presents New Data from its CC-42344 Phase 1 Influenza A Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Partnersjules abrahamSam leeRelationsjody cainInternational society for influenzaAntiviral group conferenceIsirvthe international society for influenzaCocrystal pharma incContract research organizationWall streetAnnual international societyAntiviral groupHuman studyNovel broad spectrum influenzaInternational societyRespiratory virus diseasesCocrystal pharma

SeaStar Medical (ICU) Submits IDE for a Novel Therapy to Reduce Hyperinflammation in Adult Acute AK Patients

SeaStar Medical (ICU) Submits IDE for a Novel Therapy to Reduce Hyperinflammation in Adult Acute AK Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Consultingpatty caballeroKevin chungEric schlorffRelationsjody cainSeastar medical holding corporationCompany selective cytopheretic deviceDrug administrationSeastar medical incStar medicalSelective cytopheretic devicePre market approvalHumanitarian device exemptionChief executive officerBreakthrough device designationChief medical officerSeastar medical

Cocrystal Pharma, Inc (COCP) Reports Favorable Safety and Tolerability Results from Phase 1 Study of CC-42344

Cocrystal Pharma, Inc (COCP) Reports Favorable Safety and Tolerability Results from Phase 1 Study of CC-42344
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomSam leeJames martinRelationsjody cainPartnersjules abrahamCenters for diseaseCocrystal pharma incHealthcare products regulatory agencyUnited kingdom medicinesDisease controlCocrystal pharmaInc cocrystal pharmaNobel prize winningNote regarding forward looking statementsthisPrivate securities litigation reform actAnnual report

Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A

Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomSam leeRelationsjody cainPartnersjules abrahamCocrystal pharma incWorld antiviral congress onHealthcare products regulatory agencyWall streetWorld antiviral congressUnited kingdom medicinesCocrystal pharmaInc cocrystal pharmaNobel prize winningPrivate securities litigation reform actAnnual reportJules abraham